Skip to content
← Back to this collection

PUBLICATIONS · 37407001

Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2023 Jul 6
First author
Mato AR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Mato AR
      type
      Author
    2. name
      Woyach JA
      type
      Author
    3. name
      Brown JR
      type
      Author
    4. name
      Ghia P
      type
      Author
    5. name
      Patel K
      type
      Author
    6. name
      Eyre TA
      type
      Author
    7. name
      Munir T
      type
      Author
    8. name
      Lech-Maranda E
      type
      Author
    9. name
      Lamanna N
      type
      Author
    10. name
      Tam CS
      type
      Author
    11. name
      Shah NN
      type
      Author
    12. name
      Coombs CC
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Mato AR
      type
      Author
    2. name
      Woyach JA
      type
      Author
    3. name
      Brown JR
      type
      Author
    4. name
      Ghia P
      type
      Author
    5. name
      Patel K
      type
      Author
    6. name
      Eyre TA
      type
      Author
    7. name
      Munir T
      type
      Author
    8. name
      Lech-Maranda E
      type
      Author
    9. name
      Lamanna N
      type
      Author
    10. name
      Tam CS
      type
      Author
    11. name
      Shah NN
      type
      Author
    12. name
      Coombs CC
      type
      Author
    bibliography ids
    1. nci-bib-fa2583fb1cb7d49c30e3aff8
    book metadata
    content sha256
    dbbd9b58a87ff4cb410c789e26d498b95bdb16e37bfd8f14b0d86d46e22b1f6a
    document type
    citation
    dois
    1. 10.1056/NEJMoa2300696
    electronic publication date
    display
    Source null
    precision
    missing
    year
    Source null
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:37407001
    immutable id
    pubmed:37407001@dbbd9b58a87ff4cb410c789e26d498b95bdb16e37bfd8f14b0d86d46e22b1f6a
    journal
    abbreviation
    N Engl J Med
    issn electronic
    1533-4406
    issn print
    0028-4793
    issue
    1
    name
    The New England journal of medicine
    nlm unique id
    0255562
    pages
    33-44
    volume
    389
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      37407001
      provenance
      batch id
      5329a5d0877ee70ecd11
      provider
      NCBI PubMed ESummary
      record sha256
      440a8d8d96e222f7896b513b5511a8b8622d894c8ce81d139ef25bbdc7851da5
      response sha256
      bcc4d4935bae07b2d0bf7ef24187cf1ff9d849601f315c9dbe2002bd5de6f631
      retrieved at
      2026-09-09T23:48:15.763286+00:00
      publication date
      display
      2023 Jul 6
      precision
      day
      year
      2023
      publication types
      1. Clinical Trial, Phase I
      2. Clinical Trial, Phase II
      3. Journal Article
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/37407001/
      title
      Pirtobrutinib after a Covalent BTK Inhibitor in Chronic Lymphocytic Leukemia.

      Preserved source evidence · Not medical advice